¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"amino acid side chain"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
¿µ¹® acid ÇÑ±Û »ê
¼³¸í   
  ¹°¿¡ ³ì¾ÒÀ» ¶§ ÀÌ¿ÂÈ­ÇÏ¿© ¼ö¼Ò ÀÌ¿ÂÀ» ¸¸µå´Â ¹°Áú. ½Å¸ÀÀÌ ³ª°í Ã»»ö ¸®Æ®¸Ó½º Á¾À̸¦ ºÓ°Ô º¯È­½ÃŰ¸ç ¿°±â¿ÍÀÇ ÁßÈ­ ¹ÝÀÀ¿¡ ÀÇÇÏ¿© ¹°°ú ¿°À» ¸¸µé°í ÀÌ¿ÂÈ­ ¿­¿¡¼­ ¼ö¼Òº¸´Ù ¾Õ¿¡ Àִ ±Ý¼Ó°ú ¹ÝÀÀÇÏ¿© ¿°À» ¸¸µé¸é¼­ ¼ö¼Ò¸¦ ¹ß»ý½ÃŲ´Ù. ¼ö¼Ò ¿øÀÚ¸¦ ÀÌ¿ÂÈ­Çϴ ÈûÀÇ °­¾à¿¡ µû¶ó °­»ê°ú ¾à»êÀ¸·Î ³ª´¶´Ù.
¿µ¹® acetic acid ÇÑ±Û ¾Æ¼¼Æ®»ê, ÃÊ»ê
¼³¸í   
  ºÐÀÚ½ÄÀº C2H4O2, ºÐÀÚ·® 60.05ÀÇ Àú±Þ Áö¹æ»êÀÌ´Ù. CH3COOHÀÇ ±¸Á¶½ÄÀ» °¡Áø ¹«»ö¾×ü·Î 16.7¡É¿¡¼­ ³ì°í 118.0¡É¿¡¼­ ²ú´Â´Ù. ½ÄÃÊÀÇ ½Å¸ÀÀ» ³»´Â °ÍÀ̰í, ³óÃàµÈ °ÍÀ» ºùÃÊ»êÀ̶ó ÇÑ´Ù. »ó¿Â¿¡¼­´Â ¾×üÀ̸砼ö¿ë¾×Àº ¾à»ê¼ºÀÌ´Ù. »ýü³»¿¡¼­´Â ÀϹÝÀûÀ¸·Î ¾Æ¼¼Æ¿ CoA·Î Á¸ÀçÇϸ砾Ƽ¼Æ¿±âÀÇ °ø±Þ¿øÀÌ µÇ´Â ¿Ü¿¡ Áö¹æ»êÀ̳ª ½ºÅ×·ÎÀ̵堵îÀÇ »ý¼ºÀç·á·Î Áß¿äÇÏ´Ù. ¾Æ¼¼Æ¿ CoA·ÎºÎÅʹ ÄÉÅæÃ¼°¡ ÇÕ¼ºµÇ¸ç Á¶Á÷ÀÇ ¿¡³ÊÁö¿øÀÌ µÈ´Ù.
¿µ¹® acetylsalicylic acid ÇÑ±Û ¾Æ¼¼Æ¿»ì¸®½Ç»ê
¼³¸í   
  »óǰ¸íÀÌ ¾Æ½ºÇǸ°(asprin)ÀΠ¾à. ´ëÇ¥ÀûÀΠºñ½ºÅ×·ÎÀ̵å Ç׿°¾àÀÌ´Ù. Áï Ç׿°Áõ(anti-inflammatory), ÁøÅë(analgesis), ÇØ¿­(anti-pyretic)ÀÇ È¿°ú°¡ ¸ðµÎ ¶Ù¾î³ªÁö¸¸ À§ÀåÀå¾Ö, °ú´ÙÈ£Èí, ¶óÀÌÁõÈıº(Reye syndrome) µîÀÇ ºÎÀÛ¿ëÀÌ ÀÖ´Ù.
¿µ¹® uric acid ÇÑ±Û ¿ä»ê
¼³¸í   
  °áÁ¤¼ºÀÇ »ê. 2, 6, 8-trioxypurine. È­ÇнÄÀº C5H4N4O3·Î »ç¶÷°ú µ¿¹°ÀÇ ¿ÀÁÜ¿¡¼­ ¾òÀ» ¼ö ÀÖ´Ù. ÇÙÀÇ ´ë»ç»ê¹°ÀÇ Çϳª. ¹°, ¾ËÄÝ, ¿¡Å׸£(ether)¿¡´Â °ÅÀÇ ³ìÁö ¾ÊÀ¸³ª ¾ËÄ®¸®¿°ÀÇ ¿ë¾×¿¡´Â ³ì´Â´Ù. À̰ÍÀÇ ³ªÆ®·ý¿° ÇüÅÂ(sodium urate)°¡ °á¼®ÀÇ ´ëºÎºÐÀ» Â÷ÁöÇÑ´Ù. ±Þ¼º¹éÇ÷º´ Ä¡·á Ãʱâ´Ü°è¿Í Åëdz(Gout)¿¡¼­ Ç÷Áß¿ä»êÀÌ ±Þ°ÝÈ÷ ¿À¸¦ ¼ö ÀÖ´Ù. 
¿µ¹® acid-fast bacillus ÇÑ±Û Ç׻긷´ë±Õ, Ç×»ê±Õ
¼³¸í   
  ¾Æ´Ò¸° »ö¼Ò¿¡ ¿°»öµÇ±â Èûµå³ª ÀÏ´Ü ¿°»öµÇ¸é °­»êÀ¸·Î Ã³¸®ÇÏ¿©µµ Å»»öµÇÁö ¾Æ´ÏÇϴ ¼¼±ÕÀ» ÅëÆ²¾î À̸£´Â ¸». °áÇØ±Õ, ³ªº´±Õ µûÀ§°¡ ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • working side
    ÀÛ¾÷ÂÊ, ÀÛ¾÷Ãø
  • closed chain
    ´ÝÈù»ç½½
  • closed-chain compound
    ´ÝÈù»ç½½È­ÇÕ¹°
  • cold chain
    Àú¿ÂÀ¯Áö¸Á
  • chain
    »ç½½, ¿¬¼â
  • chain compound
    »ç½½È­ÇÕ¹°
  • chain cystourethrography
    »ç½½¹æ±¤¿äµµÁ¶¿µ(¼ú)
  • chain fiber
    Çٻ罽¼¶À¯, Çٻ罽±ÙÀ°¼¼Æ÷
  • chain initiation reaction
    ¿¬¼â°³½Ã¹ÝÀÀ
  • chain reaction
    ¿¬¼â¹ÝÀÀ
  • chain saw
    »ç½½Åé
  • chain termination method
    »ç½½Á¾·á¹ý, ¿¬¼âÁ¾·á¹ý
  • chromosome chain
    ¿°»öü»ç½½, ¿°»öü°í¸®
  • food chain
    ¸ÔÀ̻罽
  • gamma chain disease
    °¨¸¶»ç½½º´
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • arachidonic acid
    ¾Æ¶ó۵·»ê
  • arsenic acid
    ºñ»ê
  • ascorbic acid
    ¾Æ½ºÄÚ¸£ºó»ê
  • calcium ethylenediaminetetraacetic acid
    Ä®½·¿¡Æ¿·»µð¾Æ¹Î»ç¾Æ¼¼Æ®»ê
  • delta-aminolevulinic acid
    µ¨Å¸¾Æ¹Ì³ë·¹ºÒ¸°»ê
  • deoxyribonucleic acid
    µð¿Á½Ã¸®º¸ÇÙ»ê, µð¿£¿¡ÀÌ
  • folic acid
    Æú»ê, ¿±»ê
  • hippuric acid
    È÷Ǫ¸£»ê, ¸¶´¢»ê
  • hydrochloric acid
    ¿°»ê
  • mandelic acid
    ¸¸µ¨¸°»ê
  • methylhippuric acid
    ¸ÞÆ¿¸¶´¢»ê
  • nucleic acid
    ÇÙ»ê
  • organic acid
    À¯±â»ê
  • oxalic acid
    ¿Á»ì»ê
  • propionic acid
    ÇÁ·ÎÇǿ»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • side effect
    ºÎÀÛ¿ë
  • side hole
    °ç±¸¸Û
  • side
    ÂÊ, Ãø, ¸é, °ç, ºÎ
  • working side
    ÀÛ¾÷ÂÊ
  • chain
    »ç½½
  • chain compound
    »ç½½È­ÇÕ¹°
  • chain cystourethrography
    »ç½½¹æ±¤¿äµµÁ¶¿µ¼ú
  • chain fiber
    (¢¡nuclear chain fiber) Çٻ罽¼¶À¯, Çٻ罽±ÙÀ°¼¼Æ÷
  • chain reaction
    ¿¬¼â¹ÝÀÀ
  • chain saw
    »ç½½Åé
  • chain structure
    »ç½½±¸Á¶, ¿¬¼â±¸Á¶
  • chain initiation reaction
    ¿¬¼â°³½Ã¹ÝÀÀ
  • chain termination method
    ¿¬¼âÁ¾·á¹ý
  • chromosome chain
    ¿°»öü»ç½½, ¿°»öü°í¸®
  • closed chain
    ´ÝÈù»ç½½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • amino sugar
    ¾Æ¹Ì³ë´ç(¡­ÓØ).
  • amino terminal
    ¾Æ¹Ì³ëÁ¾´Ü<¸»´Ü>.
  • renal amino aciduria
    ½Å¼º ¾Æ¹Ì³ë»ê´¢
  • 3,4-dihydroxyphenylacetic acid, homogentisic acid
    3,4-µðÈ÷µå·Ï½ÃÆä´Ò ¾Æ¼¼Æ¾»ê= È£¸ð°Õƾ»ê
  • abietinic acid ; abietic acid
    ¾Æºñ¿¡Æ¾»ê.
  • acetic anhydride-acetic acid-sulfuric acid
    ¹«¼öÃÊ»ê-ÃÊ»ê-Ȳ»ê
  • acid-base balance=acid-base equilibrium
    »ê¿°±â ÆòÇü(¡­øÁû¬)
  • hydroxyindoleacetic acid, 5-hydroxyindoleacetic acid (5-hiaa)
    5-ÇÏÀ̵å·Ï½ÃÀε¹¾Æ¼¼Æ®»ê
  • H chain
    Áß¼â, Á߻罽, H¼â
  • H chain disease
    H-¼âº´, Á߼⺴.
  • H chain disease
    Á߼⺴
  • J chain
    J¼â, J»ç½½
  • J chain
    J »ç½½
  • L chain
    °æ¼â, °æ»ç½½, L¼â
  • Mu heavy chain disease
    Mu Áß¼âÁúȯ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • essential amino acid
    Çʼö(ù±âÎ)¾Æ¹Ì³ë»ê
  • excitatory amino acid
    ÈïºÐ¼º ¾Æ¹Ì³ë»ê
  • gamma amino butyric acid =GABA
    °·¸¶¾Æ¹Ì³ëºêƼ¸£»ê.
  • gamma amino butyric acid =GABA
    °¨¸¶¾Æ¹Ì³ëºÎƼ¸£»ê.
  • metabolic defect of amino acid (alkaptonuria)
    ¾Æ¹Ì³ë»ê´ë»ç°áÇÔ(¾Ëİſ´¢Áõ)
  • nonessential amino acid
    ºñÇʼö¾Æ¹Ì³ë»ê
  • sulfur-containing amino acid
    Ȳ(üÜ)ÇÔÀ¯¾Æ¹Ì³ë»ê
  • amino apheresis machine
    ¾Æ¹Ì³ëºÐ¹Ý¼ú±â±â
  • amino compound
    ¾Æ¹Ì³ëÈ­ÇÕ¹°(¡­ûùùêÚª).
  • amino group
    ¾Æ¹Ì³ë±â(¡­Ðñ).
  • amino sugar
    ¾Æ¹Ì³ë´ç(¡­ÓØ).
  • amino terminal
    ¾Æ¹Ì³ëÁ¾´Ü<¸»´Ü>.
  • essential amino acids
    Çʼö¾Æ¹Ì³ë»ê.
  • renal amino aciduria
    ½Å¼º ¾Æ¹Ì³ë»ê´¢
  • autonomic side effects
    ÀÚÀ²½Å°æ°è ºÎÀÛ¿ë
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • amino acid attachement site
    ¾Æ¹Ì³ë»ê(ß«) ºÎÂø(ݾó·)ÀÚ¸®
  • amino acid composition
    ¾Æ¹Ì³ë»ê Á¶¼º(ðÚà÷)
  • amino acid incorporation
    ¾Æ¹Ì³ë»ê(ß«) ÆíÀÔ(øºìý)
  • amino acid nitrogen
    ¾Æ¹Ì³ë»ê(ß«) Áú¼Ò(òòáÈ)
  • amino acid oxidase
    ¾Æ¹Ì³ë»ê(ß«) ¿Á½Ãµ¥À̽º
  • amino acid replacement
    ¾Æ¹Ì³ë»ê(ß«) ´ëü(ÓÛôð)
  • amino acid residue
    ¾Æ¹Ì³ë»ê(ß«) Àܱâ(íÑÐñ)
  • amino acid sequence
    ¾Æ¹Ì³ë»ê(ß«) ¼­¿­(ßíæê)
  • amino acid sequencer
    ¾Æ¹Ì³ë»ê(ß«) ¼­¿­°áÁ¤±â(ßíæê̽ïÒÐï)
  • amino acid starvation
    ¾Æ¹Ì³ë»ê(ß«) ±â¾Æ(ÑÆä»)
  • amino acid substitution
    ¾Æ¹Ì³ë»ê ġȯ(öÇüµ)
  • aromatic amino acid
    ¹æÇâÁ·(Û»úÅðé) ¾Æ¹Ì³ë»ê(ß«)
  • basic amino acid
    ¿°±â¼º(ç¤Ðñàõ) ¾Æ¹Ì³ë»ê(ß«)
  • tert-BOC-amino acid
    Å͸£Æ®-BOC-¾Æ¹Ì³ë»ê(ß«)
  • CBZ-amino acid
    (å²) carbobenzoxy-¾Æ¹Ì³ë»ê(ß«)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • folic acid
    Æú»ê, ¿±»ê
  • lactic acid
    ¶ôÆ®»ê, Á¥»ê, À¯»ê
  • lactic acid dehydrogenase
    ¶ôÆ®»êÅ»¼ö¼ÒÈ¿¼Ò
  • maleic acid
    ¸»·¹»ê
  • nitric acid
    Áú»ê
  • organic acid
    À¯±â»ê
  • oxalic acid
    ¿Á»ì»ê
  • ribonucleic acid
    ¸®º¸ÇÙ»ê
  • salicylic acid
    »ì¸®½Ç»ê
  • saturated fatty acid
    Æ÷È­Áö¹æ»ê
  • unsaturated fatty acid
    ºÒÆ÷È­Áö¹æ»ê
  • uric acid
    ¿ä»ê
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AAN AIDS-associated nephropathy; alpha-amino nitrogen; American Academy of Neurology; American Academy o...
BCAA Branched Chain Amino Acid
BCAA branched chain amino acid
BCT brachiocephalic trunk; branched-chain amino acid transferase
CSCI corticosterone side-chain isomerase
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
SCC Side-chain cleavage
SCC side chain cleavage enzyme
BCAA Branched Chain Amino Acid
EPS Extrapyramidal side effects
SSC Side scatter
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • branched chain
    Ãø¼â
  • chain
    ¿¬¼â, ¼â, °í¸®, »ç½½
    ¼±»óÀ¸·Î ´ç°ú ´çÀÌ °áÇÕµÈ ÁýÇÕ¹°. ¿¹ÄÁ´ë È­ÇÕ¹°¿¡ À־ ¿øÀÚ È¤Àº ±âÀÇ ÁýÇÕ, ¶Ç´Â °³°³ ¼¼±ÕÀÌ ¿°ÁÖ ¸ð¾çÀ¸·Î µÈ ¼¼Æ÷ ¸ðÀÓ.
  • chain compound
    »ç½½ È­ÇÕ¹°
  • chain fiber
    ¿¬¼â ¼¶À¯
  • chain initiation reaction
    ¿¬¼â °³½Ã ¹ÝÀÀ
  • chain reflex
    ¿¬¼â ¹Ý»ç
    ÇϳªÀÇ Àڱؿ¡¼­ ´ÙÀ½ÀÇ ÀÚ±ØÀ¸·Î Â÷·Ê·Î ÀüÇØÁ®¼­ ¿ÏÀüÇÑ È°µ¿À¸·Î ³ªÅ¸³ª´Â ÀÏ·ÃÀÇ ¹Ý»ç.
  • chain structure
    ¿¬¼â ±¸Á¶
  • H chain
    Áß¼â, Á߻罽, H¼â
  • heavy chain
    H »ç½½, H ¼â, Áß¼â
    1. ¸é¿ª ±Û·ÎºÒ¸°ÀÇ ÇÑ ºÎºÐ. 2. ¸é¿ª ±Û·ÎºÒ¸°À» ±¸¼ºÇϰí ÀÖ´Â µÎ °³ÀÇ ºÐÀÚ¼âÀÇ ºÐÀÚ·®ÀÌ Å« Æú¸®ÆéŸÀ̵带 ¸»ÇÑ´Ù.
  • heavy chain disease
    H ¼âº´, Á߼⺴
    ´ÜŬ·Ð¼ºÀÇ °¨¸¶ ±Û·ÎºÒ¸° ÀÌ»óÀ¸·Î¼­, Ç׿ø¼º °áÁ¤ ÀÎÀÚ°¡ °á¿©µÈ ¸é¿ª ±Û·ÎºÒ¸°ÀÌ »ý»êµÈ´Ù.
  • J chain
    J¼â, J »ç½½, ¿¬°á »ç½½
  • joining chain
    ¿¬°á »ç½½, ¿¬°á ¼â
  • L chain
    °æ¼â, °æ»ç½½, L¼â
  • lambda chain
    ¶÷´Ù »ç½½
  • lateral chain
    Ãø¼â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
activated amino acid The product formed by the condensation of the acyl radical of an amino acid and adenosine 5'-monophosphate (originally in the form of adenosine 5'-triphosphate, with elimination of a pyrophosphoric group). Formed in the first step of protein biosynthesis.
Synonym: activated amino acid.
(05 Mar 2000)
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid <chemical> Alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid. An ibotenic acid homolog and glutamate agonist. The compound is the defining agonist for the ampa subtype of glutamate receptors (receptors, ampa). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.
Pharmacological action: excitatory amino acid agonists.
Chemical name: 4-Isoxazolepropanoic acid, alpha-amino-2,3-dihydro-5-methyl-3-oxo-
(12 Dec 1998)
alpha-amino acid Typically, an amino acid of the general formula R-CHNH2-COOH (i.e., the NH2 in the a position); the l forms of these are the hydrolysis products of proteins. In rarer usages, this class of molecules also includes alpha-amino phosphoric acids and alpha-aminosulfonic acids.
(05 Mar 2000)
alpha-amino acid esterase <enzyme> Converts alpha-amino acid esters and water to alpha-amino acids and alcohol
Registry number: EC 3.1.1.43
Synonym: alpha-amino acid ester hydrolase
(26 Jun 1999)
alpha-amino-beta-ketoadipic acid 2-Amino-3-oxo-1,6-hexanedioic acid;an intermediate of porphobilinogen synthesis formed by d-aminolevulinic acid synthase from succinyl-CoA and glycine; it rapidly decarboxylates to d-aminolevulinic acid.
(05 Mar 2000)
amino acid <biochemistry> A class of organic molecules that containing an amino group and can combine in linear arrays to form proteins in living organisms.
There are twenty common amino acids: alanine, arginine, aspargine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, and valine.
They are key components in all living things from which proteins are synthesised by formation of peptide bonds during ribosomal translation of messenger RNA.
All the amino acids have the L configuration, except glycine which is not optically active. Other amino acids occurring in proteins, such as hydroxyproline in collagen, are formed by post translational enzymatic modification of amino acid residues in polypeptide chains.
There are also several important amino acids, such as the neurotransmitter y aminobutyric acid, that have no relation to proteins.
Amino acids can now be produced by biotechnology in bulk using fermentation and biotransformation.
Acronym: AA
(13 Nov 1997)
amino acid activating enzyme <enzyme> Enzymes catalyzing the formation of a specific aminoacyl-tRNA from an amino acid and adenosine 5'-triphosphate with the concomitant formation of adenosine 5'-monophosphate and pyrophosphate.
Synonym: amino acid activating enzyme, aminoacyl-tRNA ligases.
(05 Mar 2000)
amino acid activation The first step of protein synthesis, whereby an amino acid reacts with adenosine triphosphate in the presence of aminoacyl RNA synthetase to produce an amino acid adenylate, which provides the energy necessary for the attachment of the amino acid to a specific transfer RNA molecule.
(12 Dec 1998)
amino acid analysis Determination and identification of amino acid content of a macromolecule, identification of a specific amino acid in macromolecules, often a mutated protein, identification and quantitation of amino acid content in blood plasma or urine; a key diagnostic aid.
(05 Mar 2000)
amino acid chloromethyl ketones <chemical> Inhibitors of serine proteinases and sulfhydryl group-containing enzymes. They act as alkylating agents and are known to interfere in the translation process.
Pharmacological action: alkylating agents, protein synthesis inhibitor, serine proteinase inhibitors.
(12 Dec 1998)
amino acid dehydrogenases Enzymes catalyzing the oxidative deamination of amino acids to the corresponding oxo (keto) acids; two relatively non-specific varieties exist, l and d, for which l-amino acids and d-amino acids are the respective substrates; the products include NH3 and a reduced hydrogen acceptor (NADH in the l case); amino acid dehydrogenases of greater specificity exist, (e.g., glycine dehydrogenase).
Compare: amino acid oxidases.
(05 Mar 2000)
amino acid isomerases <enzyme> Enzymes that catalyze either the racemization or epimerization of chiral centres within amino acids or derivatives.
Registry number: EC 5.1.1.-
(12 Dec 1998)
amino acid naphthylamidases <enzyme> Registry number: EC 3.4.11.
(12 Dec 1998)
amino acid neurotransmitters Amino acids released by neurons as intercellular messengers. Among the amino acid neurotransmitters are glutamate (glutamic acid) and gaba which are, respectively, the most common excitatory and inhibitory neurotransmitters in the central nervous system.
(12 Dec 1998)
amino acid oxidases Flavoenzymes oxidizing, with O2 and H20, either l-or d-amino acids specifically, to the corresponding 2-keto acids, NH3 and H2O2.
Compare: amino acid dehydrogenases, yellow enzyme.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • no side
    ·°ºñ °æ±â³¡(½ÉÆÇ¿ë¾î)
  • off side
    ¹Ý´ëÃøÀÇ;¿ÀÇÁ»çÀ̵åÀÇ
  • prompt side
    ÇÁ·ÒÇÁÅͰ¡ ÀÖ´Â ÂÊ(°´¼®¿¡¼­ º¸¾Æ ¿ÞÂÊÀÌ¸ç ¹è¿ìÀÇ ¿À¸¥ÂÊÀÓ)
  • re-side
    (Áý¾ÈÀÇ)ÆÇº®À» °¥¾Æ³¢¿ì´Ù
  • side
    ÂÊ;°Ñ;º¯µÎ¸®;Ç÷Åë;Àß³­Ã¼Çϱâ;¿·±¸¸®;(ÀûÆí,¿ì¸®ÆíÀÇ)Æí;ÀÚ±âÆí;°¡;³¡;º¯µÎ¸®;(¾Æ¹öÁöÂÊ,¾î¸Ó´ÏÂÊÀÇ)ÂÊ;°è;Ç÷Åë;by the ~ of;...ÀÇ °ç¿¡;...¿Í ºñ±³ÇÏ¿©;change ~s º¯ÀýÇÏ´Ù;on the large ~ Á» Å«ÆíÀÎ
  • side arms
    ÈÞ´ë ¹«±â(±ÇÃÑ,°Ë µûÀ§)
  • side dish
    (ÁÖ¿ä ¸®¿¡)°çµé¿© ³»´Â ¿ä¸®
  • side effect
    ºÎÀÛ¿ë
  • side horse
    ¾È¸¶
  • side issue
    Áö¿±ÀûÀÎ ¹®Á¦
  • side light
    Ãø¸é±¤;¿·Ã¢;¿ì¿¬ÇÑ Á¤º¸
  • side line
    Ãø¼±;ºÎ¾÷;³»Á÷;»çÀ̵å¶óÀÎÀÇ ¹Ù±ùÂÊ;³»°¢
  • side meat
    =BACON
  • side order
    º°µµ ÁÖ¹®ÀÇ(Á» ´õ ¸Ô°í ½ÍÀ» ¶§ÀÇ ÁÖ¹®)
  • side show
    ¿©Èï;Áö¿±Àû ¹®Á¦
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á